Elevated IL‐33 and increased ILC2 correlate with worsening of the endometriotic lesions and fibrosis, suggesting that IL‐33 and ILC2 may be new targets for potential therapeutic intervention in endometriosis [27]. This evidence concerns the gene IL33 and endometriosis.